Balanced news tone
News Sentiment
EQL sentiment intelligence
EQL Pharma AB news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
48
Balanced news tone
7 relevant articles
News tone and price action are not far from neutral.
68/100 classification confidence.
directly relevant articles
high-authority source matches
-2.1% over one week, -4.9% over four weeks, trend inactive, and below fair value.
EQL Pharma Calls AGM, Proposes No Dividend and New Incentive Plan
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
68/100 classification
One-week reaction
-2.1%
Price reacting lower
Trend fit
Trend inactive
-4.9% over four weeks
Fair value
-63.7%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
0
Neutral
6
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
TipRanks
Direct company coverage
EQL Pharma Calls AGM, Proposes No Dividend and New Incentive Plan
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 17 Jul 2026 09:21
- Source
- TipRanks
TradeVenue
Direct company coverage
Notice of annual general meeting in EQL Pharma AB
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 08:33
- Source
- TradeVenue
TipRanks
Direct company coverage
EQL Pharma’s Mellozzan Wins Approval in Kazakhstan, Extending Niche Generics Reach
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 15 Jul 2026 08:47
- Source
- TipRanks
TipRanks
Direct company coverage
EQL Pharma Sets August 7 Date for Q1 2026/27 Interim Report Presentation
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 11:35
- Source
- TipRanks
simplywall.st
Direct company coverage
This Analyst Just Downgraded Their EQL Pharma AB (publ) (STO:EQL) EPS Forecasts
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
EQL Pharma AB (publ) (STO:EQL) Shares Slammed 26% But Getting In Cheap Might Be Difficult Regardless
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Oct 2025 07:00
- Source
- simplywall.st
Biostock
Direct company coverage
EQL Pharma drops after profit warning
- Tone
- Negative 31/100
- Event
- Earnings
- Published
- 23 Sep 2025 07:00
- Source
- Biostock